CBAY

Cymabay Therapeutics

Delisted

CBAY was delisted on the 21st of March, 2024.

34 hedge funds and large institutions have $45.5M invested in Cymabay Therapeutics in 2017 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
34
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$4.9M
2 +$4.75M
3 +$3.34M
4
GTC
Ghost Tree Capital
New York
+$2.15M
5
JGC
J. Goldman & Co
New York
+$1.7M

Top Sellers

1 -$1.63M
2 -$353K
3 -$215K
4
UBS Group
UBS Group
Switzerland
-$14.1K
5
Creative Planning
Creative Planning
Kansas
-$7K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$7.91M
2
$6.86M
3
$6.08M
4
$4.51M
5
$3.53M
6
$3.34M
7
$3.12M
8
$2.27M
9
$2.15M
10
$1.3M
11
$997K
12
$724K
13
$513K
14
$379K
15
$234K
16
$226K
17
$169K
18
$164K
19
$133K
20
$130K
21
$129K
22
$105K
23
$86K
24
$74K
25
$71K